(Q34215052)

31 July 2017

1 reference

title

Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal (English)

1 reference

31 July 2017

Lelli G

1

1 reference

31 July 2017

Montanari M

2

1 reference

31 July 2017

Gilli G

3

1 reference

31 July 2017

Scapoli D

4

1 reference

31 July 2017

Antonietti C

5

1 reference

31 July 2017

Scapoli D

6

1 reference

31 July 2017

publication date

1 June 2003

1 reference

31 July 2017

published in

Journal of Chemotherapy

1 reference

31 July 2017

volume

15

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

220-225

1 reference

Metabolic abnormalities in cachexia and anorexia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Food intake and body composition in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

The role of cytokines in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Parenteral versus enteral nutrition in cancer patients: indications and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Managing cancer-related anorexia/cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Corticosteroids as adjuvant analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Potential novel uses of thalidomide: focus on palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Body-composition changes in patients who gain weight while receiving megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

A review of the drug treatment of cachexia associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

Cachexia and asthenia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

The role of cytokines in cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.220

10.1179/JOC.2003.15.3.220

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference